Bautista, Remejane S.

HRN: 28-68-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFUROXIME 750MG (VIAL)
03/08/2026
03/15/2026
IV
750mg
Q8h
Uti
Checking Initial Appropriateness 
03/11/2026
CEFUROXIME 750MG (VIAL)
03/11/2026
03/17/2026
IV
750
Q8
UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: